Issue 2
-
New findings from SAFIR02-BREAST and NeoTRIPaPDL1 trials presented on first day of #SABCS21
Tuesday’s General Session featured presentations on abstracts that covered topics such as the clinical utility of molecular tumor profiling and imaging mass cytometry in triple-negative breast cancer.
-
COVID-19 continues to impact breast cancer treatment, trials, and outcomes
A session on Tuesday explored how the effects of the pandemic will be felt throughout the breast cancer community for years to come.
-
Brinker Award clinical research recipient highlights key role of genetic testing in breast cancer
In recognition of her trailblazing work in clinical cancer genetics, Judy E. Garber, MD, MPH, received the Susan G. Komen® Brinker Award for Scientific Distinction in Clinical Research on Tuesday.
-
Brinker Award basic science recipient discusses neoadjuvant therapy response predictors in breast cancer
This year’s recipient of the Susan G. Komen® Brinker Award for Scientific Distinction in Basic Science, Carlos Caldas, MD, FMedSci, was honored for his groundbreaking work in breast cancer genomics.
-
William L. McGuire Memorial Lecture — Olufunmilayo Olopade, MD, FAACR
A pioneer in the fields of cancer genetics and personalized medicine, Olufunmilayo Olopade, MD, FAACR, will receive the William L. McGuire Memorial Lecture Award on Wednesday, December 8, at SABCS 2021.